BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31798347)

  • 1. High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients.
    Chen Y; Sun Y; Cui Y; Lei Y; Jiang N; Jiang W; Wang H; Chen L; Luo J; Chen Y; Tang K; Zhou C; Ke Z
    Cancer Cell Int; 2019; 19():318. PubMed ID: 31798347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
    Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
    Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
    Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
    Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
    Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
    J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
    Meng C; Zhang Y; Jiang D; Wang J
    World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.
    Liu W; Fu XL; Yang JY; Yang MW; Tao LY; Liu DJ; Huo YM; Zhang JF; Hua R; Sun YW
    Am J Cancer Res; 2016; 6(8):1820-7. PubMed ID: 27648368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
    Liu K; Li X; Yang Z; Zhang R
    Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
    Yin WH; Fan HZ; Sheng JW; Xia HM; Wu YW; Xie P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):673-5. PubMed ID: 23888454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
    Liu Y; Abulimiti N; Wang C
    Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.
    Zhong R; Yang M; Zhu R; Zhang J; Wang L
    Oncol Lett; 2023 Apr; 25(4):133. PubMed ID: 36909370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
    Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
    Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
    Li N; Chen L; Liu C; Jiang Y; Rong J
    Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.
    Zhou H; Su L; Liu C; Li B; Li H; Xie Y; Sun D
    Onco Targets Ther; 2019; 12():7823-7831. PubMed ID: 31576140
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huang L; Yin Y; Qian D; Cao Y; Wang D; Wu X; Ming L; Huang Z; Zhou L
    J Thorac Dis; 2023 Apr; 15(4):2022-2036. PubMed ID: 37197507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
    Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
    Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cthrc1 overexpression is an independent prognostic marker in gastric cancer.
    Gu L; Liu L; Zhong L; Bai Y; Sui H; Wei X; Zhang W; Huang P; Gao D; Kong Y; Lou G
    Hum Pathol; 2014 May; 45(5):1031-8. PubMed ID: 24746208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.